Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair loss

Study of safety and effectiveness of mesenchymal stem cells condition medium in the treatment of hair loss (phases I and II )

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200127046282N13

Enrollment

Registered

2022-05-01

Start date

2022-04-14

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hair loss. Nonscarring hair loss, unspecified

Interventions

Intervention 1: Control group: One side of the physiological serum is injected. This will be done once a month for 3 months. Intervention 2: Intervention group: Wharton jelly mesenchymal stem cells co

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients who do not want to take minoxidil. Patients who are allergic to minoxidil.

Exclusion criteria

Exclusion criteria: The patient has used an effective drug in hair loss during the last 6 months.

Design outcomes

Primary

Measure	Time frame
The amount of hair loss. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Trichoscan.	—

Secondary

Measure	Time frame
Side effects. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.;Effectiveness. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.	—

Measure

Time frame

Side effects. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.;Effectiveness. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSona Zare

Skin and Stem cell Research Center of Tehran University of Medical Sciences

sonazarebio@gmail.com+98 21 2665 7438

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026